Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
Women with hot flashes
, especially when they are causing sleep disturbance,
consider hormone therapy (HT). Estrogen given short-term is the most effective treatment for hot
flashes, and benefit of short-term (less than 5 years) use outweighs potential
risks for most women.
Because the risks outweigh the benefits of long-term
hormone therapy (HT) for most women, women who are at risk of, or who have been diagnosed with,
osteoporosis should talk to their doctors about non-estrogen medications such
as alendronate (Fosamax), risedronate (Actonel), raloxifene (Evista),
teriparatide (Forteo), and calcitonin (Miacalcin) in preventing and treating osteoporosis.
Women with vaginal dryness or itching due to menopause
can consider HT. Oral pills, skin
patches, gel, or vaginal forms of estrogen can be used. Women who only have
vaginal menopause symptoms and are not experiencing hot flashes should pick a
vaginal form of estrogen, whereas women with both hot flashes and vaginal
symptoms can use any form of ET. Sometimes, if a woman has both hot flashes and
vaginal symptoms, both oral and vaginal forms of ET will be prescribed together,
especially if vaginal symptoms do not improve with oral ET alone.
It is recommended that women who do not choose to take hormone therapy
should take the lowest effective dose for the shortest time period possible.